Keravision(kera) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Keravision(kera)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Rubin who wrote (206)	8/12/1999 11:26:00 AM
From: Jeff Vayda	Read Replies (1) of 338

Secondary might have been placed higher, but just how much flexibility does the company have? They need the money now to support the expansion of training. They have seen that they are swamped with doctors wanting to get licensed. They might have disagreed with the firm's placement, and they might well be right. Best thing would have been to agree to the lower price and have an option to increase the amount tendered. A couple of dollars here will be rewarded later when the additional training capacity comes on line. KERA gets part of every procedure - the faster they can get doctors out and working the better. Near term, this should put a damper on the stock price from EPS and capex numbers, but in 6 months when more doctors are in the system, the incoming numbers will be strong enough to push past these levels. This procedure is so far ahead of Laser that as the word spreads it will take off. I look forward to more doctors in the loop in order to drive the price of the procedure down. You think demand in good now, wait until the price drops 50%. Might be a little cloudy now, but nothing but blue skies ahead. Jeff Vayda

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next